Alaunos Therapeutics, Inc. (TCRT) stock
TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.72+0.06 (+3.61%)
Close on Nov 18, 2026Market cap $4.37MP/E –Yield –
Alaunos Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Alaunos Therapeutics's price to sales ratio was 456.4× on Jul 31, 2025, against 46.9× a year earlier. Over the last 4 years it ranged from 6.6× to 494.7×, with a median of 235.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 456.4× | +449.8 |
| 2023 | Oct 31, 2023 | 6.6× | −275.6 |
| 2022 | May 31, 2022 | 282.1× | +99.2 |
| 2019 | Jan 31, 2019 | 183.0× | +30.2 |
| 2018 | Dec 31, 2018 | 152.8× | −298.0 |
| 2014 | Apr 30, 2014 | 450.7× | −3.3 |
| 2013 | Dec 31, 2013 | 454.0× | +40.0 |
| 2012 | Dec 31, 2012 | 414.0× | – |
See a number that looks wrong?